Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by FEINSTEIN, A.
Right arrow Articles by RON, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FEINSTEIN, A.
Right arrow Articles by RON, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 115, No. 5, 1403-1415, 1992
© 1992 Guarantors of Brain


research-article

ACUTE OPTIC NEURITIS

A COGNITIVE AND MAGNETIC RESONANCE IMAGING STUDY

ANTHONY FEINSTEIN1, BRYAN YOUL2 and MARIA RON1

1Department of Neuropsychiatry London, UK 2Department of Clinical Neurology, Institute of Neurology London, UK

Correspondence to: Correspondence to: Dr A Feinstein, Institute of Neurology, Queen Square House, Queen Square, London WCIN 3BG, UK.

Forty-two patients with acute optic neuritis (ON) (mean duration of symptoms 14. 5 d) were compared with a matched, normal control group on a battery of tests of attention and information processing speed Approximately half the sample (55%) had brain abnormalities shown by magnetic resonance imaging (MRI) and were more impaired across a variety of tests compared with those patients without brain lesions or normal controls There was no difference in psychometric performance other than the pegboard task between the normal control group and those ON patients without brain involvement Significant correlations were found between total lesion area in the brain and some tests of attention. Results from the Symbol Digit-Substitution Test were particularly sensitive in this regard and could correctly identify 70% of the sample with brain lesions.

Received September 23, 1991. Revised February 18, 1992. Accepted April 8, 1992.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
O. Garcea, A. Villa, F. Caceres, T. Adoni, M. Alegria, R. Barbosa Thomaz, R. Buzo, L. Llamas Lopez, and M. Rivera Kindel
Early treatment of multiple sclerosis: a Latin American Experts Meeting
Multiple Sclerosis, October 1, 2009; 15(3_suppl): S1 - S12.
[Abstract] [PDF]


Home page
Mult SclerHome page
P Nilsson, I Rorsman, E. Larsson, B Norrving, and M Sandberg-Wollheim
Cognitive dysfunction 24-31 years after isolated optic neuritis
Multiple Sclerosis, August 1, 2008; 14(7): 913 - 918.
[Abstract] [PDF]


Home page
NeurologyHome page
O. Ghaffar and A. Feinstein
Multiple sclerosis and cannabis: A cognitive and psychiatric study
Neurology, July 15, 2008; 71(3): 164 - 169.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
B. Glanz, C. Holland, S. Gauthier, E. Amunwa, Z. Liptak, M. Houtchens, R. Sperling, S. Khoury, C. Guttmann, and H. Weiner
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis
Multiple Sclerosis, September 1, 2007; 13(8): 1004 - 1010.
[Abstract] [PDF]


Home page
Mult SclerHome page
L Feuillet, F Reuter, B Audoin, I Malikova, K Barrau, A A. Cherif, and J Pelletier
Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis
Multiple Sclerosis, January 1, 2007; 13(1): 124 - 127.
[Abstract] [PDF]


Home page
BrainHome page
S. J. Camp, V. L. Stevenson, A. J. Thompson, G. T. Ingle, D. H. Miller, C. Borras, B. Brochet, V. Dousset, M. Falautano, M. Filippi, et al.
A longitudinal study of cognition in primary progressive multiple sclerosis
Brain, December 1, 2005; 128(12): 2891 - 2898.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. Chamelian, M. Reis, and A. Feinstein
Six-month recovery from mild to moderate Traumatic Brain Injury: the role of APOE-{varepsilon}4 allele
Brain, December 1, 2004; 127(12): 2621 - 2628.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. Birnboim and A. Miller
Cognitive strategies application of multiple sclerosis patients
Multiple Sclerosis, February 1, 2004; 10(1): 67 - 73.
[Abstract] [PDF]


Home page
BrainHome page
C. Wegner and P.M. Matthews
A new view of the cortex, new insights into multiple sclerosis
Brain, August 1, 2003; 126(8): 1719 - 1721.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Zarei, S Chandran, A Compston, and J Hodges
Cognitive presentation of multiple sclerosis: evidence for a cortical variant
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 872 - 877.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Feinstein
An examination of suicidal intent in patients with multiple sclerosis
Neurology, September 10, 2002; 59(5): 674 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R Zivadinov, J Sepcic, D Nasuelli, R De Masi, L M. Bragadin, M A Tommasi, S Zambito-Marsala, R Moretti, A Bratina, M Ukmar, et al.
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, June 1, 2001; 70(6): 773 - 780.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. J. Camp, V. L. Stevenson, A. J. Thompson, D. H. Miller, C. Borras, S. Auriacombe, B. Brochet, M. Falautano, M. Filippi, L. Herisse-Dulo, et al.
Cognitive function in primary progressive and transitional progressive multiple sclerosis: A controlled study with MRI correlates
Brain, July 1, 1999; 122(7): 1341 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Weinstein, S. I. L. Schwid, R. B. Schiffer, M. P. McDermott, D. W. Giang, and A. D. Goodman
Neuropsychologic Status in Multiple Sclerosis After Treatment With Glatiramer
Arch Neurol, March 1, 1999; 56(3): 319 - 324.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.